- Home
- MAIA vs ONMD Comparison
MAIA vs ONMD Comparison
Compare MAIA & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- ONMD
- Stock Information
- Founded
- MAIA 2018
- ONMD 2006
- Country
- MAIA United States
- ONMD United States
- Employees
- MAIA N/A
- ONMD N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- MAIA Health Care
- ONMD
- Exchange
- MAIA Nasdaq
- ONMD Nasdaq
- Market Cap
- MAIA 44.9M
- ONMD 43.5M
- IPO Year
- MAIA 2022
- ONMD N/A
- Fundamental
- Price
- MAIA $1.11
- ONMD $1.47
- Analyst Decision
- MAIA
- ONMD
- Analyst Count
- MAIA 0
- ONMD 0
- Target Price
- MAIA N/A
- ONMD N/A
- AVG Volume (30 Days)
- MAIA 747.3K
- ONMD 995.5K
- Earning Date
- MAIA 11-07-2025
- ONMD 12-16-2025
- Dividend Yield
- MAIA N/A
- ONMD N/A
- EPS Growth
- MAIA N/A
- ONMD N/A
- EPS
- MAIA N/A
- ONMD N/A
- Revenue
- MAIA N/A
- ONMD $459,000.00
- Revenue This Year
- MAIA N/A
- ONMD N/A
- Revenue Next Year
- MAIA N/A
- ONMD N/A
- P/E Ratio
- MAIA N/A
- ONMD N/A
- Revenue Growth
- MAIA N/A
- ONMD N/A
- 52 Week Low
- MAIA $1.05
- ONMD $0.30
- 52 Week High
- MAIA $3.48
- ONMD $4.22
- Technical
- Relative Strength Index (RSI)
- MAIA 34.52
- ONMD 37.03
- Support Level
- MAIA $1.05
- ONMD $1.70
- Resistance Level
- MAIA $1.35
- ONMD $1.84
- Average True Range (ATR)
- MAIA 0.10
- ONMD 0.22
- MACD
- MAIA -0.03
- ONMD -0.16
- Stochastic Oscillator
- MAIA 12.85
- ONMD 6.43
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.